Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Characterization of fusion transcripts in AML without recurrent genetic abnormalities unravels new putative fusion genes. Local targets link to admitted publications; unresolved targets remain external evidence.
Discovering and understanding oncogenic gene fusions through data intensive computational approaches
10.1093/nar/gkw282 · 2016 · External reference
Recent advances in cancer fusion transcript detection
10.1093/bib/bbac519 · 2023 · External reference
The landscape and therapeutic relevance of cancer-associated transcript fusions
10.1038/onc.2014.406 · 2015 · External reference
Driver fusions and their implications in the development and treatment of human cancers
10.1016/j.celrep.2018.03.050 · 2018 · External reference
Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center
10.1038/s41408-021-00504-5 · 2021 · External reference
A new genomic framework to categorize pediatric acute myeloid leukemia
10.1038/s41588-023-01640-3 · 2024 · External reference
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
10.1182/blood-2015-07-604496 · 2016 · External reference
The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
10.1038/s41375-022-01613-1 · 2022 · External reference
International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphological, clinical, and genomic data
10.1182/blood.2022015850 · 2022 · External reference
Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS
10.1182/bloodadvances.2020003007 · 2020 · External reference
Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing
10.1038/s41375-020-0762-8 · 2021 · External reference
Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements
10.3324/haematol.2021.278436 · 2021 · External reference
Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia
10.1038/s41375-023-02102-9 · 2024 · External reference
STAR-fusion: fast and accurate fusion transcript detection from RNA-seq
2017 · External reference
Allele-specific copy number analysis of tumors
10.1073/pnas.1009843107 · 2010 · External reference
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
10.1182/blood-2011-04-346643 · 2011 · External reference
Two myeloid leukemia cases with rare FLT3 fusions
10.1101/mcs.a003079 · 2018 · External reference
Wasf3 deficiency reveals involvement in metastasis in a mouse model of breast cancer
10.1016/j.ajpath.2019.08.012 · 2019 · External reference
Targeting the WASF3 complex to suppress metastasis
10.1016/j.phrs.2022.106302 · 2022 · External reference
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
10.1182/bloodadvances.2023010805 · 2024 · External reference
Crosstalk between β-catenin and WT1 signaling activity in acute myeloid leukemia
10.3324/haematol.2021.280294 · 2023 · External reference
The clinical impact of PTPN11 mutations in adults with acute myeloid leukemia
10.1038/s41375-020-0920-z · 2021 · External reference
AML classification in the year 2023: how to avoid a Babylonian confusion of languages
10.1038/s41375-023-01909-w · 2023 · External reference
The menin-MLL1 interaction is a molecular dependency in NUP98 -rearranged AML
10.1182/blood.2021012806 · 2022 · External reference
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms
10.1182/blood.2019003691 · 2020 · External reference
Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
10.1016/j.jmoldx.2016.10.002 · 2017 · External reference
RUNX1 translocations in malignant hemopathies
2009 · External reference
ETV6 fusion genes in hematological malignancies: a review
10.1016/j.leukres.2012.04.010 · 2012 · External reference
Emerging entities in NUTM1-rearranged neoplasms
10.1002/gcc.22838 · 2020 · External reference
Identification of a novel AVEN-NUTM1 fusion gene in acute myeloid leukemia
10.1111/ijlh.13519 · 2021 · External reference
RhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domain
10.1016/j.celrep.2013.04.017 · 2013 · External reference
Glypican-3 expression in clear cell adenocarcinoma of the ovary
10.1038/modpathol.2009.40 · 2009 · External reference
Expression of GPC3 protein and its significance in lung squamous cell carcinoma
10.1007/s12032-011-9973-1 · 2012 · External reference
Glypican-3: a molecular marker for the detection and treatment of hepatocellular carcinoma
10.1016/j.livres.2020.11.003 · 2020 · External reference
How chromosomal translocations arise to cause cancer: Gene proximity, trans-splicing, and DNA end joining
10.1016/j.isci.2023.106900 · 2023 · External reference
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia
10.1016/j.cell.2014.02.019 · 2014 · External reference
A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression
10.1016/j.ccr.2014.02.008 · 2014 · External reference
Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector
10.1016/j.crmeth.2023.100467 · 2023 · External reference
The fusion of CLEC12A and MIR223HG arises from a trans-splicing event in normal and transformed human cells
10.3390/ijms222212178 · 2021 · External reference
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
10.1182/blood.2022016867 · 2022 · External reference
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
10.1182/blood-2009-11-254441 · 2010 · External reference
